What SSRI (Selective Serotonin Reuptake Inhibitor) or SNRI (Serotonin-Norepinephrine Reuptake Inhibitor) is least associated with sexual dysfunction side effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

SSRI/SNRI with Least Sexual Dysfunction: Bupropion is the Clear Winner

Bupropion should be your first-line choice when sexual dysfunction is a concern, as it has dramatically lower rates of sexual side effects (8-10%) compared to all SSRIs and SNRIs. 1, 2

Evidence-Based Ranking of Sexual Dysfunction Risk

Lowest Risk (Preferred)

  • Bupropion (not technically an SSRI/SNRI) has sexual dysfunction rates of only 8-10%, making it significantly superior to all SSRIs and SNRIs 1, 2
  • Bupropion was associated with significantly less sexual dysfunction than both fluoxetine and sertraline in direct comparisons 3, 4

Among True SSRIs (if bupropion is contraindicated)

  • Escitalopram and fluvoxamine cause the lowest rates of sexual dysfunction among SSRIs, though exact rates are not specified 2
  • Sertraline has moderate sexual dysfunction rates (14% ejaculatory failure in males, 6% decreased libido overall) 2
  • Fluoxetine and citalopram have intermediate rates of sexual dysfunction 2
  • Paroxetine has the highest rates at 70.7% and should be avoided when sexual function is a concern 1, 2

SNRIs

  • Venlafaxine and duloxetine both impair sexual function and should be avoided when libido is a concern 1
  • SNRIs are associated with higher discontinuation rates due to adverse effects (including sexual dysfunction) compared to SSRIs as a class 3

Clinical Decision Algorithm

Step 1: Consider Bupropion First

  • Start with bupropion 150-400 mg/day when sexual function is a priority 1
  • Bupropion has comparable antidepressant efficacy to SSRIs but with dramatically fewer sexual side effects 5, 4, 6

Step 2: Screen for Bupropion Contraindications

  • Do not use bupropion in patients with seizure disorders, eating disorders (bulimia/anorexia), or those who are agitated 1, 2
  • Seizure risk increases at doses above 300 mg/day 1, 2
  • Avoid in patients with abrupt alcohol or benzodiazepine discontinuation 1

Step 3: If Bupropion is Contraindicated, Choose Among SSRIs

  • First choice: Escitalopram or fluvoxamine (lowest sexual dysfunction among SSRIs) 2
  • Second choice: Sertraline or citalopram (intermediate rates) 2
  • Avoid: Paroxetine (70.7% sexual dysfunction rate—the worst offender) 1, 2

Step 4: Consider Mirtazapine as Alternative

  • Mirtazapine has lower rates of sexual dysfunction than SSRIs 2
  • However, it causes significant sedation and weight gain, which may limit tolerability 3, 2

Critical Caveats and Pitfalls

Underreporting of Sexual Dysfunction

  • Sexual dysfunction rates in clinical trials are vastly underreported—real-world incidence is likely much higher than published figures 1, 2
  • Proactively ask patients about sexual side effects within 1-2 weeks of starting treatment 1

Anxiety Comorbidity

  • Bupropion has less established efficacy for anxiety disorders compared to SSRIs 1
  • If significant anxiety is present, you may need to balance sexual side effects against anxiety control 7
  • Psychiatrists often avoid prescribing bupropion for patients with high anxiety, despite limited evidence supporting differential response 7

Special Population: Breast Cancer Patients on Tamoxifen

  • Avoid paroxetine and fluoxetine in patients on tamoxifen due to CYP2D6 inhibition reducing tamoxifen efficacy 2
  • Prefer venlafaxine, citalopram, or bupropion in this population 3, 2

Dose-Related Effects

  • Sexual side effects of SSRIs are strongly dose-related—higher doses increase both efficacy and sexual dysfunction 2
  • Consider using the minimum effective dose to balance depression control with sexual function 2

Monitoring Requirements

  • Assess sexual function and other adverse effects within 1-2 weeks of initiating therapy 1, 2
  • If inadequate response or intolerable side effects occur within 6-8 weeks, modify treatment 1, 2
  • About 40% of patients discontinue antidepressants within 12 months due to side effects, including sexual dysfunction 2

References

Guideline

SSRIs and Sexual Dysfunction in Men: Medication Selection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

SSRI-Associated Sexual Dysfunction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Why isn't bupropion the most frequently prescribed antidepressant?

The Journal of clinical psychiatry, 2005

Related Questions

What is the difference between bupropion SR and bupropion XL for treatment?
Does bupropion (Bupropion) XR 150mg twice daily show efficacy in treating major depressive disorder?
What are the considerations and guidelines for using Aplenzin (bupropion) in adults with major depressive disorder, particularly those with a history of depression, anxiety, or other mental health conditions?
What are the benefits of taking Wellbutrin (bupropion)?
What can be added to Wellbutrin (bupropion) for a patient with persistent low energy and fatigue, who is also taking Lexapro (escitalopram) for Major Depressive Disorder (MDD) and Risperdal (risperidone) for anger outbursts?
For a 64-year-old patient with COVID-19, influenza B, and streptococcal infection, is it advisable to start two antivirals simultaneously?
Can a patient with COVID-19 and congested sinuses use Polysporin (neomycin and polymyxin B) antibiotic ear drops?
What alternative medication can be used for surgical pain management in an older adult patient with hypotension (low blood pressure), acute kidney injury (AKI) on chronic kidney disease (CKD), and abnormal liver function?
What is the appropriate duration of intravenous (IV) antibiotic therapy for a patient with gram-positive bacteremia due to Streptococcus pyogenes and evidence of endocarditis on transesophageal echocardiogram (TEE)?
What is the appropriate diagnosis and management plan for a patient exhibiting hypersexual behavior without full amnesia, considering potential underlying psychiatric or neurological conditions?
What are the indications for a D-dimer (Deep vein thrombosis/pulmonary embolism marker) test in adults with suspected deep vein thrombosis (DVT) or pulmonary embolism (PE)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.